1. Dayer P, Desmeules J, Collart L. Pharmacology of tramadol. Drugs 1997;53(Suppl 2):18-24. PMID:
9190321.
2. Desmeules JA, Piguet V, Collart L, Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 1996;41:7-12. PMID:
8824687.
3. Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC. Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology (Berl) 2010;211:457-466. PMID:
20589494.
4. Freye E, Levy J. Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram®): a case study. Eur J Pain 2000;4:307-311. PMID:
10985875.
5. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119. PMID:
14592341.
6. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132. PMID:
14592342.
7. Barsotti CE, Mycyk MB, Reyes J. Withdrawal syndrome from tramadol hydrochloride. Am J Emerg Med 2003;21:87-88. PMID:
12563592.
8. Thomas AN, Suresh M. Opiate withdrawal after tramadol and patient-controlled analgesia. Anaesthesia 2000;55:826-827. PMID:
10947728.
9. Scherbaum N, Stüper B, Bonnet U, Gastpar M. Transient restless legs-like syndrome as a complication of opiate withrawal. Pharmacopsychiatry 2003;36:70-72. PMID:
12734764.
10. Park YM, Cho JH, Lim YS, Lee HJ, Kang SG, Kim L. The withdrawal from TDF therapy could induce transient RLS. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:419-420. PMID:
20005913.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245. PMID:
7249508.
12. Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993;16:327-332. PMID:
8341893.
13. Walters AS, Winkelmann J, Trenkwalder C, Fry JM, Kataria V, Wagner M, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001;16:1105-1109. PMID:
11748742.
14. von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkheimer F, Tings T, et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 2005;128:906-917. PMID:
15728657.
15. Walters AS, Ondo WG, Zhu W, Le W. Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study. J Neurol Sci 2009;279:62-65. PMID:
19167016.
16. Morris BJ, Johnston HM. A role for hippocampal opioids in long-term functional plasticity. Trends Neurosci 1995;18:350-355. PMID:
7482797.
17. Walker JM, Thompson LA, Frascella J, Friederich MW. Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat. Eur J Pharmacol 1987;134:53-59. PMID:
3030781.
18. Manning BH, Mao J, Frenk H, Price DD, Mayer DJ. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 1996;67:79-88. PMID:
8895234.
19. Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology (Berl) 2012;223:1-15. PMID:
22526529.
20. Jensen JB. Dependence after treatment with tramadol. Ugeskr Laeger 1997;159:785
21. Miranda HF, Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol Biochem Behav 1998;61:357-360. PMID:
9802828.